SNX13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.571200E-01
Normal-vs-Stage2
2.767600E-01
Normal-vs-Stage3
2.122400E-02
Normal-vs-Stage4
9.097400E-01
Stage1-vs-Stage2
1.072620E-01
Stage1-vs-Stage3
4.281500E-02
Stage1-vs-Stage4
8.701800E-01
Stage2-vs-Stage3
6.423700E-04
Stage2-vs-Stage4
2.764600E-01
Stage3-vs-Stage4
6.531900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.533800E-01
Normal-vs-AfricanAmerican
8.834800E-01
Normal-vs-Asian
3.130800E-01
Caucasian-vs-AfricanAmerican
2.902400E-01
Caucasian-vs-Asian
6.119400E-01
AfricanAmerican-vs-Asian
2.710200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.402800E-01
Normal-vs-Female
4.377800E-01
Male-vs-Female
5.088000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.469400E-01
Normal-vs-Age(41-60Yrs)
7.527600E-01
Normal-vs-Age(61-80Yrs)
2.386000E-01
Normal-vs-Age(81-100Yrs)
1.744190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.252200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.502200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.655400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.957100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.566300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.331200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.046560E-01
Normal-vs-Daily Drinker
1.599810E-01
Normal-vs-Weekly Drinker
1.702640E-01
Normal-vs-Occasional Drinker
8.470600E-01
Normal-vs-Social Drinker
8.200200E-01
Non Drinker-vs-Daily Drinker
8.994400E-01
Non Drinker-vs-Weekly Drinker
8.833400E-01
Non Drinker-vs-Occasional Drinker
1.715570E-02
Non Drinker-vs-Social Drinker
1.087990E-01
Daily Drinker-vs-Weekly Drinker
9.766600E-01
Daily Drinker-vs-Occasional Drinker
3.326500E-02
Daily Drinker-vs-Social Drinker
8.743900E-02
Weekly Drinker-vs-Occasional Drinker
5.790000E-02
Weekly Drinker-vs-Social Drinker
1.325400E-01
Occasional Drinker-vs-Social Drinker
8.940800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.524170E-01
Normal-vs-Grade 2
5.020100E-02
Normal-vs-Grade 3
6.319700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.791210E-01
Grade 1-vs-Grade 3
6.747400E-01
Grade 1-vs-Grade 4
1.524170E-01
Grade 2-vs-Grade 3
1.193970E-01
Grade 2-vs-Grade 4
5.020100E-02
Grade 3-vs-Grade 4
6.319700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.327170E-01
Normal-vs-NonDiabetic
3.676200E-01
Diabetic-vs-NonDiabetic
7.311600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.868400E-02
Normal-vs-NoPancreatitis
3.294400E-01
Pancreatitis-vs-NoPancreatitis
2.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.371200E-01
Normal-vs-N1
3.056000E-01
N0-vs-N1
9.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.082000E-01
Normal-vs-TP53-NonMutant
8.646600E-01
TP53-Mutant-vs-TP53-NonMutant
9.456000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
